Dr. De Jesus Acosta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
401 N. Broadway
Baltimore, MD 21231Phone+1 410-955-8964- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2007 - 2010
- VA Caribbean Healthcare SystemResidency, Internal Medicine, 2003 - 2007
- University of Puerto Rico School of MedicineClass of 2003
Certifications & Licensure
- FL State Medical License 2022 - Present
- MD State Medical License 2007 - 2024
- NC State Medical License 2020 - 2022
- PA State Medical License 2005 - 2022
- PR State Medical License 2005 - 2010
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Publications & Presentations
PubMed
- 3 citationsHealth-related quality of life with pembrolizumab monotherapy in patients with previously treated advanced microsatellite instability high/mismatch repair deficient en...D M O'Malley, G M Bariani, P A Cassier, A Marabelle, A R Hansen, A De Jesus Acosta, W H Miller Jr, T Safra, A Italiano, L Mileshkin, M Amonkar, L Yao, F Jin, K Norwood...> ;Gynecologic Oncology. 2022 Aug 1
- 3 citationsHealth-related quality of life in patients treated with pembrolizumab for microsatellite instability-high/mismatch repair-deficient advanced solid tumours: Results fro...Michele Maio, Mayur M Amonkar, Josephine M Norquist, Paolo A Ascierto, Ludmila Manzyuk, Daniel Motola-Kuba, Nicolas Penel, Philippe A Cassier, Giovanni M Bariani, Ana ...> ;European Journal of Cancer. 2022 Jul 1
- 93 citationsPembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study.M Maio, P A Ascierto, L Manzyuk, D Motola-Kuba, N Penel, P A Cassier, G M Bariani, A De Jesus Acosta, T Doi, F Longo, W H Miller, D-Y Oh, M Gottfried, L Xu, F Jin, K N...> ;Annals of Oncology. 2022 Sep 1
- Join now to see all
Other Languages
- Spanish
Hospital Affiliations
- Johns Hopkins HospitalBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/ana-de-jesus-acosta
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: